Genetic testing is now standard of care for patients with IRD. A genetic diagnosis can guide treatment decisions and determine eligibility for gene-based therapies, clinical trials, registers and natural history studies.

This online learning module and clinical audit will support you to achieve the best long-term treatment outcomes for your patients with IRD.

Genetic testing is now standard of care for patients with IRD. A genetic diagnosis can guide treatment decisions and determine eligibility for gene-based therapies, clinical trials, registries and natural history studies.

This learning module provides an introduction to IRD before discussing the genetic diagnosis of IRDs and management of patients with IRD after a genetic diagnosis.

Pharmacists play an important role in relieving the burden of migraine through timely supply of Schedule 3 triptans for treatment. Learn more via case studies and interviews with a pharmacist.